PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Estimated NAV at 30 April 2015

29 May 2015 07:05

RNS Number : 5721O
Standard Life Euro Pri Eqty Tst PLC
29 May 2015
 

29 May 2015

STANDARD LIFE EUROPEAN PRIVATE EQUITY TRUST PLC ("SLEPET" OR "THE COMPANY") ANNOUNCES ITS ESTIMATED NET ASSET VALUE ("NAV") AT 30 APRIL 2015

· ESTIMATED NAV AT 30 APRIL 2015 WAS 269.9 PENCE PER SHARE (NAV AT 31 MARCH 2015 WAS 268.6 PENCE PER SHARE)

· SLEPET RECEIVED £12.3 MILLION OF DISTRIBUTIONS AND PAID £1.0 MILLION OF DRAW DOWNS DURING THE MONTH OF APRIL

· SLEPET HAD £270.1 MILLION OF OUTSTANDING COMMITMENTS AT 30 APRIL 2015

SLEPET's valuation policy for private equity funds is based on the latest valuations reported by the managers of the funds in which SLEPET has holdings. In the case of SLEPET's valuation at 30 April 2015, 100% of the reported portfolio valuations were dated 31 March 2015.

 

Estimated NAV

At 30 April 2015, SLEPET's estimated NAV was 269.9 pence per share (estimated net assets £424.6 million), representing a 0.5% per share increase from the NAV at 31 March 2015 of 268.6 pence per share (net assets £422.5 million).

 

Draw downs and distributions

SLEPET paid £1.0 million of draw downs and received £12.3 million of distributions during the month. The distributions received generated net realised gains and income of £6.9 million.

 

Commitments

A new commitment of €30.0 million was made to Equistone Partners Europe Fund V in April. The Company had £270.1 million of outstanding commitments at 30 April 2015. After undertaking a detailed review, the Manager continues to believe that up to £50 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

Balance sheet and credit facility

The Company had liquid resources of £58.4 million at 30 April 2015, comprising a cash balance of £26.7 million and £31.7 million invested at value (£29.5 million at cost) in UK and European equity index tracker funds. The Company has an undrawn £80 million syndicated revolving credit facility led by The Royal Bank of Scotland plc that expires in December 2016.

 

Future announcements

The Company is expecting to announce its estimated NAV at 31 May 2015 on or around 12 June 2015.

 

 

 

 

Additional detail about SLEPET's NAV and investment diversification can be found on SLEPET's website. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website is incorporated into, or forms part of, this announcement.

For further information please contact Peter McKellar or Roger Pim at SL Capital Partners LLP (0131 245 0055)

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

Valuation Methodology

Unquoted investments are stated at the directors' estimate of fair value and follow the recommendations of EVCA and BVCA. The estimate of fair value is normally the latest valuation placed on a fund by its manager at the balance sheet date. The valuation policies used by the manager in undertaking that valuation will generally be in line with the joint publication from EVCA and BVCA, 'International Private Equity and Venture Capital Valuation guidelines'. Where formal valuations are not completed at the balance sheet date the last available valuation from the fund manager is adjusted for any subsequent cashflows occurring between the valuation date and the balance sheet date. The Company's Manager may further adjust such valuations to reflect any changes in circumstances from the last manager's formal valuation date to arrive at the estimate of fair value. Quoted investments are valued based on quoted prices as of the last day of the relevant period.

The Company intends to release regular estimated NAV updates around ten business days after each month end, while continuing to issue quarterly trading statements. A breakdown of SLEPET's portfolio can be obtained in the latest monthly factsheet, which is published on the Manager's website at www.slcapital.com/IT_European_Private_Equity/getLatest.pdf

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVPGUPGAUPAGMR
Date   Source Headline
16th Mar 20117:30 amRNSQuarterly Trading Statement
31st Jan 20113:54 pmRNSDirector/PDMR Shareholding
31st Jan 20113:53 pmRNSDirector/PDMR Shareholding
31st Jan 201111:50 amRNSTotal Voting Rights
31st Jan 201111:03 amRNSDirector/PDMR Shareholding
27th Jan 201111:03 amRNSAnnual Financial Report
26th Jan 20119:33 amRNSIssue of Equity
25th Jan 20114:08 pmRNSResult of AGM
25th Jan 20111:00 pmRNSInterim Management Statement
17th Jan 201111:28 amRNSDirector/PDMR Shareholding
6th Jan 20112:05 pmRNSCalculation of Script Dividend Reference Price
6th Jan 201111:28 amRNSQuarterly Disclosure
21st Dec 201011:07 amRNSDoc re. Annual Report
20th Dec 20104:26 pmRNSAnnual Information Update
8th Dec 20104:02 pmRNSDirector/PDMR Shareholding
6th Dec 20107:00 amRNSPreliminary Results for year to 30/09/10
2nd Dec 20102:30 pmRNSDirectorate Change
30th Nov 20107:00 amRNSRefinancing of debt facility
17th Nov 20109:20 amRNSDirector Declaration
4th Oct 20102:45 pmRNSQuarterly Disclosure
30th Sep 20105:30 pmRNSTotal Voting Rights
28th Sep 201010:46 amRNSApplication for Listing
22nd Sep 20107:00 amRNSInvestment update for quarter to 30 June 2010
10th Aug 201012:49 pmRNSInterim Management Statement
2nd Jun 201012:36 pmRNSHolding(s) in Company
28th May 20107:00 amRNSHalf Yearly Report
9th Apr 201012:46 pmRNSHolding(s) in Company
17th Mar 20107:00 amRNSTrading Statement
9th Feb 201011:40 amRNSDirector/PDMR Shareholding
8th Feb 201010:19 amRNSDirector/PDMR Shareholding
2nd Feb 20103:02 pmRNSDirector/PDMR Shareholding
1st Feb 201011:14 amRNSDirector/PDMR Shareholding
1st Feb 201011:12 amRNSDirector/PDMR Shareholding
1st Feb 201011:10 amRNSDirector/PDMR Shareholding
1st Feb 201011:06 amRNSTotal Voting Rights
27th Jan 20103:39 pmRNSResult of AGM
27th Jan 201012:13 pmRNSInterim Management Statement
27th Jan 201010:00 amRNSApplication for Listing
20th Jan 20109:47 amRNSHolding(s) in Company
14th Jan 201011:30 amRNSAnnual Financial Report
12th Jan 201010:39 amRNSAnnual Information Update
7th Jan 20104:41 pmRNSCalculation of scrip dividend reference price
5th Jan 201012:46 pmRNSQuarterly Disclosure
23rd Dec 200910:57 amRNSDirector/PDMR Shareholding - Replacement
17th Dec 20092:25 pmRNSDoc re. Annual Report and Circular
3rd Dec 200912:13 pmRNSDirector/PDMR Shareholding
3rd Dec 20097:00 amRNSPreliminary results for year to 30/9/09
18th Sep 20097:00 amRNSThird Quarter Trading Statement
29th Jul 20097:30 amRNSInterim Management Statement
8th Jul 20092:23 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.